|
1
|
Ferlay J, Shin HR, Bray F, et al:
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int
J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Walboomers JM, Jacobs MV, Manos MM, et al:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Noordhuis MG, Eijsink JJ, Ten HK, et al:
Expression of epidermal growth factor receptor (EGFR) and activated
EGFR predict poor response to (chemo) radiation and survival in
cervical cancer. Clin Cancer Res. 15:7389–7397. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Woelber L, Kress K, Kersten JF, et al:
Carbonic anhydrase IX in tumor tissue and sera of patients with
primary cervical cancer. BMC Cancer. 11:122011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hellberg D, Tot T and Stendahl U: Pitfalls
in immunohistochemical validation of tumor marker expression -
exemplified in invasive cancer of the uterine cervix. Gynecol
Oncol. 112:235–240. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Khunamornpong S, Settakorn J, Sukpan K, et
al: Cyclooxygenase-2 expression in squamous cell carcinoma of the
uterine cervix is associated with lymph node metastasis. Gynecol
Oncol. 112:241–247. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lima EM, Araújo JJ, Harada ML, et al:
Molecular study of the tumour suppressor gene PTEN in gastric
adenocarcinoma in Brazil. Clin Exp Med. 5:129–132. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oki E, Kakeji Y, Baba H, et al: Impact of
loss of heterozygosity of encoding phosphate and tensin homolog on
the prognosis of gastric cancer. J Gastroenterol Hepatol.
21:814–818. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stiles BL: Phosphatase and tensin
homologue deleted on chromosome 10: extending its PTENtacles. Int J
Biochem Cell Biol. 41:757–761. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Raftopoulou M, Etienne-Manneville S, Self
A, et al: Regulation of cell migration by the C2 domain of the
tumor suppressor PTEN. Science. 303:1179–1181. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li J, Yen C, Liaw D, et al: PTEN, a
putative protein tyrosine phosphatase gene mutated in human brain,
breast and prostate cancer. Science. 275:1943–1947. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo CY, Xu XF, Wu JY and Liu SF:
PCR-SSCP-DNA sequencing method in detecting PTEN gene mutation and
its significance in human gastric cancer. World J Gastroenterol.
14:3804–3811. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marsit CJ, Zheng S, Aldape K, et al: PTEN
expression in non-small-cell lung cancer: evaluating its relation
to tumor characteristics, allelic loss, and epigenetic alteration.
Hum Pathol. 36:768–776. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Teng Y, Sun AN, Pan XC, et al: Synergistic
function of Smad4 and PTEN in suppressing forestomach squamous cell
carcinoma in the mouse. Cancer Res. 66:6972–6981. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Perrone F, Lampis A, Orsenigo M, et al:
PI3KCA/PTEN deregulation contributes to impaired responses to
cetuximab in metastatic colorectal cancer patients. Ann Oncol.
20:84–90. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kang YH, Lee HS and Kim WH: Promoter
methylation and silencing of PTEN in gastric carcinoma. Lab Invest.
82:285–291. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Soria JC, Lee HY, Lee JI, et al: Lack of
PTEN expression in non-small cell lung cancer could be related to
promoter methylation. Clin Cancer Res. 8:1178–1184. 2002.PubMed/NCBI
|
|
18
|
Yang HJ, Liu VW, Wang Y, et al:
Differential DNA methylation profiles in gynecological cancers and
correlation with clinico-pathological data. BMC Cancer. 6:2122006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang YA, Fan LF, Jiang CQ, et al:
Expression and significance of PTEN, hypoxia-inducible factor-1
alpha in colorectal adenoma and adenocarcinoma. World J
Gastroenterol. 9:491–494. 2003.PubMed/NCBI
|
|
20
|
Schöndorf T, Ebert MP, Hoffmann J, et al:
Hypermethylation of the PTEN gene in ovarian cancer cell lines.
Cancer Lett. 207:215–220. 2004.PubMed/NCBI
|
|
21
|
Steck PA, Pershouse MA, Jasser SA, et al:
Identification of a candidate tumour suppressor gene, MMAC1, at
chromosome 10q23.3 that is mutated in multiple advanced cancers.
Nat Genet. 15:356–362. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yaginuma Y, Yamashita T, Ishiya T, et al:
Abnormal structure and expression of PTEN/MMAC1 gene in human
uterine cancers. Mol Carcinog. 27:110–116. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rizvi MM, Alam MS, Ali A, et al: Aberrant
promoter methylation and inactivation of PTEN gene in cervical
carcinoma from Indian population. J Cancer Res Clin Oncol.
137:1255–1262. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cheung TH, Lo KW, Yim SF, et al:
Epigenetic and genetic alternation of PTEN in cervical neoplasm.
Gynecol Oncol. 93:621–627. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wiencke JK, Zheng S, Jelluma N, et al:
Methylation of the PTEN promoter defines low-grade gliomas and
secondary glioblastoma. Neuro Oncol. 9:271–279. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang H, Kong W, He L, et al: MicroRNA
expression profiling in human ovarian cancer: miR-214 induces cell
survival and cisplatin resistance by targeting PTEN. Cancer Res.
68:425–433. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eijsink JJ, Noordhuis MG, ten Hoor KA, et
al: The epidermal growth factor receptor pathway in relation to
pelvic lymph node metastasis and survival in early-stage cervical
cancer. Hum Pathol. 41:1735–1741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lu D, Qian J, Yin X, et al: Expression of
PTEN and survivin in cervical cancer: promising biological markers
for early diagnosis and prognostic evaluation. Br J Biomed Sci.
69:143–146. 2012.PubMed/NCBI
|
